|
EORTC AISBL / IVZW |
|
|
EORTC AISBL / IVZW |
The aims of the European Organisation for Research and Treatment
of Cancer (EORTC) are to develop, conduct, coordinate, and stimulate translational
and clinical research in Europe to improve the management of cancer and related
problems by increasing survival but also patients’ quality of life.
Extensive and comprehensive research in this wide field is often beyond the
means of individual European laboratories and hospitals, and can best be accomplished
through the multidisciplinary multinational efforts of translational research scientists
and clinicians.
During the last few years, numerous innovative agents have been discovered as
a result of tremendous developments in the understanding of the molecular basis
of cancer. Further clinical progress in cancer treatment will be accomplished
mainly through the conduct of translational research projects, efficient drug
development and the execution of large, prospective, randomized, multicenter
cancer clinical trials. The EORTC promotes multidisciplinary cancer research
in Europe and is linked to other leading biomedical research organisations around
the world.
The EORTC has the aim to facilitate the passage of experimental discoveries
into state-of-the-art treatment by keeping to a minimum the time lapse between
the discovery of new anti-cancer agents and the implementation of their therapeutic
benefit for patients with cancer.
The ultimate goal of the EORTC is to improve the standard of cancer treatment
in Europe, through the evaluation of innovative drugs, and to establish more
effective therapeutic strategies, using drugs already commercially available,
or surgery and radiotherapy.
The organisation was founded as an international organisation
under Belgian law in 1962 by eminent oncologists working in the main cancer
research institutes of the EU countries and Switzerland. It was named Groupe
Européen de Chimiothérapie Anticancéreuse (GECA), and became
the European Organisation for Research and Treatment of Cancer (EORTC) in 1968.
|
|
|
|
|
|
|
|
|
|
|
|
|
2003 - 2006 |
2006 - 2009 |
||
